Continuous Glucose Monitoring Systems Market by Product Type, End-Users, & Geography (North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa): Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2030

Description

Persistence Market Research has recently published an extensive report on the global Continuous Glucose Monitoring Systems Market. The significant growth observed in this market underscores the increasing demand for advanced glucose monitoring solutions for diabetic management, driven by factors such as the rising prevalence of diabetes, technological advancements in medical devices, and growing awareness about the importance of continuous glucose monitoring. The report highlights the pivotal role of continuous glucose monitoring systems in improving diabetes management, enhancing patient outcomes, and reducing the risk of complications associated with fluctuating blood sugar levels.

The global continuous glucose monitoring systems market is forecast to expand at a CAGR of 9.3% and thereby increase from a value of US$11 Bn in 2023, to US$20.5 Bn by the end of 2030.

Key Insights

Continuous Glucose Monitoring Systems Market Size (2023E): US$ 11 billion

Projected Market Value (2030F): US$ 20.5 billion

Global Market Growth Rate (CAGR 2023 to 2030): 9.3%

Historical Market Growth Rate (CAGR 2018 to 2022): 8.2%

Continuous Glucose Monitoring Systems Market - Report Scope

The Continuous Glucose Monitoring Systems Market report provides a comprehensive analysis of market dynamics, focusing on historical trends and future projections. Continuous glucose monitoring systems enable real-time monitoring of glucose levels, offering patients and healthcare providers valuable insights into glucose fluctuations and trends. The report delves into the nuances of the continuous glucose monitoring systems market, exploring factors driving market growth, key market players, and emerging trends shaping the industry landscape.

Market Growth Drivers for Continuous Glucose Monitoring Systems Market:

The rising prevalence of diabetes worldwide, coupled with the growing demand for personalized and proactive diabetes management solutions, drives the adoption of continuous glucose monitoring systems. These systems offer several advantages over traditional glucose monitoring methods, including real-time data insights, trend analysis, and alerts for hypo- and hyperglycemia, empowering patients to make informed decisions about their diet, medication, and lifestyle choices.

Moreover, technological advancements in continuous glucose monitoring systems, such as miniaturization, improved accuracy, longer sensor wear duration, and integration with smartphone applications and wearable devices, enhance user experience and convenience. The shift towards value-based healthcare models and the emphasis on preventive care and remote patient monitoring further accelerate the adoption of continuous glucose monitoring systems, enabling early detection of glucose abnormalities and timely intervention to prevent complications.

Market Restraints

Despite the growing adoption and technological advancements, the continuous glucose monitoring systems market faces challenges related to cost, reimbursement policies, and user acceptance. The high upfront cost of continuous glucose monitoring systems, including the initial device purchase and ongoing sensor expenses, poses affordability challenges for some patients, particularly in developing economies with limited healthcare resources and insurance coverage.

Additionally, reimbursement policies vary across different regions, leading to disparities in access to continuous glucose monitoring systems and affordability barriers for patients without adequate insurance coverage. Furthermore, user acceptance and adherence to continuous glucose monitoring systems may vary among different patient populations, influenced by factors such as device comfort, accuracy, ease of use, and individual preferences. Addressing these barriers requires collaborative efforts from healthcare stakeholders, including manufacturers, regulators, payers, and healthcare providers, to ensure equitable access and adoption of continuous glucose monitoring systems.

Market Opportunities

Amidst the challenges lie opportunities for innovation and market expansion within the continuous glucose monitoring systems market. Investing in research and development to enhance device accuracy, reliability, and usability can drive wider adoption and acceptance of continuous glucose monitoring systems among diverse patient populations. Furthermore, expanding market access through strategic partnerships, distribution agreements, and patient assistance programs can improve affordability and affordability, thereby widening the addressable market for continuous glucose monitoring systems.

Moreover, leveraging digital health technologies such as artificial intelligence, machine learning, and data analytics can unlock new insights from continuous glucose monitoring data, enabling personalized diabetes management solutions and predictive analytics for early intervention and risk mitigation. Collaborating with healthcare providers, payers, and patient advocacy groups can facilitate patient education, training, and support services to enhance user acceptance and adherence to continuous glucose monitoring systems, thereby improving patient outcomes and reducing healthcare costs.

Key Questions Answered in Report::

What is the Forecast CAGR of the Continuous Glucose Monitoring Systems Market in 2030?
What is the Global Market Size of Continuous Glucose Monitoring Systems as of the End of 2023?
Which Region Dominated the Continuous Glucose Monitoring Systems Market in 2023?
Who are the Key Players in the Global Continuous Glucose Monitoring Systems Market?
Which Vertical Markets Hold the Largest Opportunities for Continuous Glucose Monitoring Systems?

Competitive Intelligence and Business Strategy

In navigating the competitive landscape, companies in the Continuous Glucose Monitoring Systems Market must leverage competitive intelligence and strategic business initiatives to differentiate themselves and capitalize on emerging opportunities. Understanding market dynamics, customer requirements, and competitor strategies is essential for informed decision-making and market positioning.

Furthermore, investing in talent development, training, and certification programs can help companies build specialized expertise and capabilities in continuous glucose monitoring systems, enhancing their competitiveness and value proposition. By investing in research and development, innovation, and strategic partnerships, companies can develop differentiated offerings, expand market reach, and capture market share in the dynamic Continuous Glucose Monitoring Systems Market.

Key Companies Profiled
Herbalife Nutrition
GNC Holdings
NOW Health
Nutramax Laboratories
Nature's Bounty
Banyan Botanicals
Source Naturals
Nutramarks Inc
Nature's Way Products
Abbott
Natural Immunogenics

Continuous Glucose Monitoring Systems Market Research Segmentation

Market segmentation based on component type, end-user, application, and region provides valuable insights into key market segments and regional dynamics, enabling companies to tailor their offerings to specific customer needs and preferences. By understanding the unique requirements of different customer segments and geographic markets, companies can develop targeted strategies to address market demands effectively, thereby gaining a competitive edge and driving growth in the Continuous Glucose Monitoring Systems Market.

By Component:
Transmitters and Monitors
Sensors
Insulin Pump
By End User:
Home Care Diagnostics
Hospitals
ICU/Critical Care
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33708

1. Executive Summary

1.1. Global Continuous Glucose Monitoring Systems Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Component Lifecycle Analysis
2.4. Continuous Glucose Monitoring Systems Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Vehicle Types
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Continuous Glucose Monitoring Systems Market Outlook: Component
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Component, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
  - 3.3.3.1. Transmitters and Monitors
  - 3.3.3.2. Sensors
  - 3.3.3.3. Insulin Pump
3.4. Market Attractiveness Analysis: Component
3.5. Global Continuous Glucose Monitoring Systems Market Outlook: End User
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.5.3.1. Home Care Diagnostics
  - 3.5.3.2. Hospitals
  - 3.5.3.3. ICU/Critical Care
3.6. Market Attractiveness Analysis: End User

4. Global Continuous Glucose Monitoring Systems Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Component
- 5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
- 5.5.1. Transmitters and Monitors
- 5.5.2. Sensors
- 5.5.3. Insulin Pump
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.6.1. Home Care Diagnostics
- 5.6.2. Hospitals
- 5.6.3. ICU/Critical Care
5.7. Market Attractiveness Analysis

6. Europe Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Component
- 6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
- 6.5.1. Transmitters and Monitors
- 6.5.2. Sensors
- 6.5.3. Insulin Pump
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.6.1. Home Care Diagnostics
- 6.6.2. Hospitals
- 6.6.3. ICU/Critical Care
6.7. Market Attractiveness Analysis

7. East Asia Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Component
- 7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
- 7.5.1. Transmitters and Monitors
- 7.5.2. Sensors
- 7.5.3. Insulin Pump
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.6.1. Home Care Diagnostics
- 7.6.2. Hospitals
- 7.6.3. ICU/Critical Care
7.7. Market Attractiveness Analysis

8. South Asia & Oceania Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Component
- 8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
- 8.5.1. Transmitters and Monitors
- 8.5.2. Sensors
- 8.5.3. Insulin Pump
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.6.1. Home Care Diagnostics
- 8.6.2. Hospitals
- 8.6.3. ICU/Critical Care
8.7. Market Attractiveness Analysis

9. Latin America Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Component
- 9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
- 9.5.1. Transmitters and Monitors
- 9.5.2. Sensors
- 9.5.3. Insulin Pump
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.6.1. Home Care Diagnostics
- 9.6.2. Hospitals
- 9.6.3. ICU/Critical Care
9.7. Market Attractiveness Analysis

10. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Component
- 10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
- 10.5.1. Transmitters and Monitors
- 10.5.2. Sensors
- 10.5.3. Insulin Pump
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.6.1. Home Care Diagnostics
- 10.6.2. Hospitals
- 10.6.3. ICU/Critical Care
10.7. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Herbalife Nutrition
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. GNC Holdings
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. NOW Health
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Nutramax Laboratories
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Nature's Bounty
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Banyan Botanicals
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Source Naturals
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Nutramarks Inc
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Nature's Way Products
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. Abbott
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. Natural Immunogenics
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Product
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Sample Report